Evidence map›Paper›PMID 30544934›Full record

ReviewNutrients2018

Iron Treatment May Be Difficult in Inflammatory Diseases: Inflammatory Bowel Disease as a Paradigm.

Carla J Gargallo-Puyuelo, Erika Alfambra, Jose Antonio García-Erce, Fernando Gomollon

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Iron Deficiency and the Small bowel​.Current gastroenterology reports · 2021
    Review
  11. Review
  12. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Carla J Gargallo-PuyueloDigestive Diseases Service, Hospital Clínico Universitario "Lozano Blesa", Zaragoza, 50009 Aragón, Spain. carlajerusalen@hotmail.com.
Erika AlfambraDigestive Diseases Service, Hospital Clínico Universitario "Lozano Blesa", Zaragoza, 50009 Aragón, Spain. ealfambra.due@gmail.com.ORCID 0000-0003-2834-8204
Jose Antonio García-ErceBlood and Tissue Bank of Navarra, Pamplona, 31008 Navarra, España. jagarciaerce@gmail.com.ORCID 0000-0001-7662-6286
Fernando GomollonDigestive Diseases Service, Hospital Clínico Universitario "Lozano Blesa", Zaragoza, 50009 Aragón, Spain. fgomollon@gmail.com.ORCID 0000-0003-0076-3529
Hospital Clínico Universitario Lozano Blesa · ESNavarrabiomed · ESUniversidad de Zaragoza · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron plays a key role in many physiological processes; cells need a very exact quantity of iron. In patients with inflammatory bowel disease, anaemia is a unique example of multifactorial origins, frequently being the result of a combination of iron deficiency and anaemia of chronic disease. The main cause of iron deficiency is the activity of the disease. Therefore, the first aim should be to reach complete clinical remission. The iron supplementation route should be determined according to symptoms, severity of anaemia and taking into account comorbidities and individual risks. Oral iron can only be used in patients with mild anaemia, whose disease is inactive and who have not been previously intolerant to oral iron. Intravenous iron should be the first line treatment in patients with moderate-severe anaemia, in patients with active disease, in patients with poor tolerance to oral iron and when erythropoietin agents or a fast response is needed. Erythropoietin is used in a few patients with anaemia to overcome functional iron deficiency, and blood transfusion is being restricted to refractory cases or acute life-threatening situations.

Indexed as

Inflammatory Bowel DiseasesIronAdministration, IntravenousAdministration, OralAnemia, Iron-DeficiencyHumansIron DeficienciesIroninflammatory bowel diseaseintravenous ironiron deficiencyiron deficiency anemiaoral iron

Identifiers

PMID30544934
PMCPMC6316243
OpenAlexW2905096245

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.